Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Dementia (Lewy Body) (Galantamine - Dementia (Lewy Body))

Records returned : 5 (on 26 Jan 2026 at 05:54:20). Return to search results for ' Dementia (Lewy Body) '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off Label

Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

SPC

View the treatment summary for {padindicationname} on https://www.medicines.org.uk

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Galantamine

Drug:

Galantamine

Indication :

Dementia (Lewy Body)

Status :

Blue

Formulations :

Modified release capsules
Oral solution

Restrictions / Comments:

Important

In Lewy Body dementia if donepezil or rivastigmine are not tolerated / unsuitable. Off-label use.

On recommendation from the mental health specialist team in patients who may or may not require ongoing follow-up from the specialist service.

Reserve oral solution for patients who are unable to swallow capsules.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

Off Label

SPC

2. Donepezil hydrochloride

Drug:

Donepezil hydrochloride

Indication :

Dementia (Lewy Body)

Status :

Blue

Formulations :

Oral solution
Oro-dispersible tablets
Tablets

Restrictions / Comments:

Important

Preferred

In Lewy Body dementia. Off-label use.

On recommendation from the mental health specialist team in patients who may or may not require ongoing follow-up from the specialist service.

Reserve oral solution and orodispersible tablets for patients who are unable to swallow tablets.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

Off Label

SPC

3. Memantine hydrochloride

Drug:

Memantine hydrochloride

Indication :

Dementia (Lewy Body)

Status :

Blue

Formulations :

Oral solution
Oro-dispersible tablets
Tablets

Restrictions / Comments:

Important

In Lewy Body dementia if AChE inhibitors are contraindicated or not tolerated. Off-label use.

On recommendation from the mental health specialist team in patients who may or may not require ongoing follow-up from the specialist service.

Reserve oral solution and orodispersible tablets for patients who are unable to swallow tablets.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Off Label

SPC

4. Rivastigmine

Drug:

Rivastigmine

Indication :

Dementia (Lewy Body)

Status :

Blue

Formulations :

Capsules
Oral solution

Restrictions / Comments:

Important

In Lewy Body dementia. Off-label use.

Suitable for primary care prescribing on recommendation from the mental health specialist team in patients who may or may not require ongoing follow-up from the specialist service.

Reserve oral solution for patients who are unable to swallow capsules.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

Off Label

SPC

5. Rivastigmine

Drug:

Rivastigmine

Indication :

Dementia (Lewy Body)

Status :

Blue

Formulations :

Patches

Restrictions / Comments:

Important

PATCHES - In Lewy Body dementia. Off-label use.

suitable for primary care prescribing on recommendation from the mental health specialist team in patients who may or may not require ongoing follow-up from the specialist service.

SAFETY WARNING - patches are available as DAILY or TWICE WEEKLY but both are described in mg/24 hours. Care required to ensure that the intended patch is prescribed and dispensed.

An MHRA alert has also been issued in response to rivastigmine overdose due to multiple patch application, cutting patches and application of patches to non-recommended sites: https://www.gov.uk/drug-safety-update/rivastigmine-exelon-transdermal-patch-risk-of-medication-errors?UNLID=7961636092025721172155

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

Off Label

SPC